CGP 3466 maleate is primarily researched for its potential neuroprotective properties. It has been studied in the context of neurodegenerative diseases, such as Parkinson's disease and Alzheimer's disease, due to its ability to modulate cell signaling pathways involved in neuronal survival. The compound is thought to inhibit apoptosis, or programmed cell death, in neurons, which could help preserve brain function in degenerative conditions. Additionally, it has been explored for its role in mitigating the effects of oxidative stress, a key factor in the progression of many neurological disorders. While still in experimental stages, its application in neuroprotection holds promise for future therapeutic developments.